BONE BIOLOGICS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.19% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-14
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.74%, a 5.56% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-03-31 was 3.96%, a 0.25% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 3.97%, a 14.99% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 4.67%.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 3.99%, a 2.84% increase from fiscal 2024.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.88%, a 11.62% decline from fiscal 2023.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.39%.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 1.21%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.19% 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | 3.74% 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | 3.99% 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | 3.99% 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | 3.99% 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | 3.96% 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | 3.88% 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | 3.49% 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | 3.97% 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | 3.97% 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | 4.39% 10-K · filed 2025-02-26 | ||||
| 2023-09-30 | 4.39% 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 4.67% 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 4.67% 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | 1.21% 10-K · filed 2023-03-30 | ||||
| 2020-09-30 | 0.00% 10-Q · filed 2021-04-15 | ||||
| 2020-06-30 | 0.00% 10-Q · filed 2021-04-15 | ||||
| 2020-03-31 | 0.00% 10-Q · filed 2021-04-15 | ||||
| 2019-12-31 | 2.55% 10-K · filed 2021-04-15 | ||||
| 2019-09-30 | 2.55% 10-Q · filed 2021-04-15 | ||||
| 2019-06-30 | 2.55% 10-Q · filed 2021-04-15 | ||||
| 2019-03-31 | 2.55% 10-Q · filed 2021-04-15 | ||||
| 2014-09-30 | 1.83% 10-Q · filed 2014-11-19 | ||||
| 2014-09-19 | 2.29% 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |